Latest Insider Transactions at Hanger, Inc. (HNGR)
This section provides a real-time view of insider transactions for Hanger, Inc. (HNGR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HANGER, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HANGER, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 03
2022
|
Kathryn M Sullivan Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
62,026
-100.0%
|
$1,116,468
$18.75 P/Share
|
|
Oct 03
2022
|
Richard Pettingill Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
78,135
-100.0%
|
$1,406,430
$18.75 P/Share
|
|
Oct 03
2022
|
Cynthia L Lucchese Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
67,851
-100.0%
|
$1,221,318
$18.75 P/Share
|
|
Oct 03
2022
|
Mark M Jones Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,594
-100.0%
|
$370,692
$18.75 P/Share
|
|
Oct 03
2022
|
Stephen E Hare Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
107,009
-100.0%
|
$1,926,162
$18.75 P/Share
|
|
Oct 03
2022
|
Thomas E Hartman SVP and General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
153,580
-100.0%
|
$2,764,440
$18.75 P/Share
|
|
Oct 03
2022
|
Keri Jolly SVP & Chief HR Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
44,411
-100.0%
|
$799,398
$18.75 P/Share
|
|
Oct 03
2022
|
Thomas E Kiraly EVP & Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
276,451
-100.0%
|
$4,976,118
$18.75 P/Share
|
|
Oct 03
2022
|
Kathleen L Means Chief Supply Chain Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,760
-100.0%
|
$103,680
$18.75 P/Share
|
|
Oct 03
2022
|
Michael H Oros President, Hanger Clinic |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,889
-100.0%
|
$304,002
$18.75 P/Share
|
|
Oct 03
2022
|
Scott Ranson EVP, Chief Info Officer * |
SELL
Sale (or disposition) back to the issuer
|
Direct |
117,479
-100.0%
|
$2,114,622
$18.75 P/Share
|
|
Oct 03
2022
|
Peter A Stoy EVP & Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
65,190
-100.0%
|
$1,173,420
$18.75 P/Share
|
|
Oct 03
2022
|
John T Fox Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
43,561
-100.0%
|
$784,098
$18.75 P/Share
|
|
Oct 03
2022
|
Thomas C Freyman Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
43,561
-100.0%
|
$784,098
$18.75 P/Share
|
|
Oct 03
2022
|
Mitchell D Dobson SVP, Chief Compliance Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
42,840
-100.0%
|
$771,120
$18.75 P/Share
|
|
Oct 03
2022
|
James H Campbell SVP, Chief Clinical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
52,391
-100.0%
|
$943,038
$18.75 P/Share
|
|
Oct 03
2022
|
Christopher B Begley Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
76,414
-100.0%
|
$1,375,452
$18.75 P/Share
|
|
Oct 03
2022
|
Asif Ahmad Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
70,837
-100.0%
|
$1,275,066
$18.75 P/Share
|
|
Oct 03
2022
|
Gabrielle B. Adams Vice President Accounting |
SELL
Sale (or disposition) back to the issuer
|
Direct |
68,930
-100.0%
|
$1,240,740
$18.75 P/Share
|
|
Oct 03
2022
|
Gabrielle B. Adams Vice President Accounting |
SELL
Bona fide gift
|
Direct |
2,442
-4.05%
|
-
|
|
Oct 03
2022
|
Vinit K Asar President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
929,994
-100.0%
|
$16,739,892
$18.75 P/Share
|
|
Oct 03
2022
|
Vinit K Asar President and CEO |
SELL
Bona fide gift
|
Direct |
10,597
-1.44%
|
-
|
|
Jul 14
2022
|
Peter A Stoy EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,031
-2.28%
|
$14,434
$14.28 P/Share
|
|
Jun 21
2022
|
Keri Jolly SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
990
-2.54%
|
$13,860
$14.51 P/Share
|
|
Jun 02
2022
|
Asif Ahmad Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,911
+12.27%
|
-
|
|
Jun 02
2022
|
Christopher B Begley Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,911
+11.48%
|
-
|
|
Jun 02
2022
|
John T Fox Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,911
+18.53%
|
-
|
|
Jun 02
2022
|
Thomas C Freyman Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,911
+18.53%
|
-
|
|
Jun 02
2022
|
Mark M Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,911
+32.49%
|
-
|
|
Jun 02
2022
|
Stephen E Hare Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,911
+8.48%
|
-
|
|
Jun 02
2022
|
Cynthia L Lucchese Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,911
+12.75%
|
-
|
|
Jun 02
2022
|
Richard Pettingill Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,911
+11.26%
|
-
|
|
Jun 02
2022
|
Kathryn M Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,911
+13.78%
|
-
|
|
Mar 15
2022
|
Thomas E Kiraly EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,750
-3.32%
|
$166,250
$19.16 P/Share
|
|
Mar 09
2022
|
Regina A Weger President, SPS |
SELL
Payment of exercise price or tax liability
|
Direct |
724
-1.31%
|
$13,756
$19.45 P/Share
|
|
Mar 09
2022
|
Gabrielle B. Adams Vice President Accounting |
SELL
Payment of exercise price or tax liability
|
Direct |
1,740
-2.58%
|
$33,060
$19.45 P/Share
|
|
Mar 09
2022
|
Vinit K Asar President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
26,805
-3.1%
|
$509,295
$19.45 P/Share
|
|
Mar 09
2022
|
James H Campbell SVP, Chief Clinical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,284
-2.71%
|
$24,396
$19.45 P/Share
|
|
Mar 09
2022
|
Mitchell D Dobson SVP, Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
943
-2.4%
|
$17,917
$19.45 P/Share
|
|
Mar 09
2022
|
Thomas E Hartman SVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,422
-2.46%
|
$65,018
$19.45 P/Share
|
|
Mar 09
2022
|
Keri Jolly SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
828
-2.08%
|
$15,732
$19.45 P/Share
|
|
Mar 09
2022
|
Thomas E Kiraly EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,246
-2.68%
|
$137,674
$19.45 P/Share
|
|
Mar 09
2022
|
Scott Ranson EVP, Chief Info Officer * |
SELL
Payment of exercise price or tax liability
|
Direct |
2,383
-2.12%
|
$45,277
$19.45 P/Share
|
|
Mar 08
2022
|
Gabrielle B. Adams Vice President Accounting |
SELL
Payment of exercise price or tax liability
|
Direct |
1,787
-2.58%
|
$33,953
$19.41 P/Share
|
|
Mar 08
2022
|
Vinit K Asar President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
25,037
-2.82%
|
$475,703
$19.41 P/Share
|
|
Mar 08
2022
|
James H Campbell SVP, Chief Clinical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,782
-3.62%
|
$33,858
$19.41 P/Share
|
|
Mar 08
2022
|
Mitchell D Dobson SVP, Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,234
-3.04%
|
$23,446
$19.41 P/Share
|
|
Mar 08
2022
|
Thomas E Hartman SVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,362
-2.36%
|
$63,878
$19.41 P/Share
|
|
Mar 08
2022
|
Keri Jolly SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,964
-4.7%
|
$37,316
$19.41 P/Share
|
|
Mar 08
2022
|
Thomas E Kiraly EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,664
-2.4%
|
$126,616
$19.41 P/Share
|